Ascendis Pharma A/S OverviewAscendis Pharma A/S Research & Development
Research & Development expenses for ASND.
Quarterly R&D Expenses
$57.63M
↓ 33.45% YoY
As of Mar 31, 2026
Annual R&D Expenses (TTM)
$271.47M
↓ 15.67% YoY
Trailing 12 months ending Mar 31, 2026